1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET BY TECHNIQUE
2.1 OVERVIEW
2.2 IN VIVO
2.2.1 IN VIVO MARKET, BY COUNTRY
2.3 IN VITRO
2.3.1 IN VITRO MARKET, BY TECHNIQUE
2.3.1.1 CELL CULTURE MARKET, BY COUNTRY
2.3.1.2 PCR MARKET, BY COUNTRY
2.3.1.3 ELISA MARKET, BY COUNTRY
2.3.1.4 WESTERN BLOTTING MARKET, BY COUNTRY
2.3.1.5 PROTEIN BINDING ASSAYS MARKET, BY COUNTRY
2.3.2 IN VITRO MARKET, BY COUNTRY
2.4 IN SILICO
2.4.1 IN SILICO MARKET, BY COUNTRY
3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET BY TOXICITY ENDPOINT
3.1 OVERVIEW
3.2 GENOTOXICITY
3.2.1 GENOTOXICITY MARKET, BY COUNTRY
3.3 DERMAL TOXICITY
3.3.1 DERMAL TOXICITY MARKET, BY COUNTRY
3.4 SKIN TOXICITY
3.4.1 SKIN TOXICITY MARKET, BY COUNTRY
3.5 OCULAR TOXICITY
3.5.1 OCULAR TOXICITY MARKET, BY COUNTRY
3.6 PHOTOTOXICITY
3.6.1 PHOTOTOXICITY MARKET, BY COUNTRY
3.7 OTHERS
3.7.1 OTHERS MARKET, BY COUNTRY
4 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET BY END USER
4.1 OVERVIEW
4.2 PHARMACEUTICAL INDUSTRY
4.2.1 PHARMACEUTICAL INDUSTRY MARKET, BY COUNTRY
4.3 COSMETIC INDUSTRY
4.3.1 COSMETIC INDUSTRY MARKET, BY COUNTRY
4.4 CHEMICAL INDUSTRY
4.4.1 CHEMICAL INDUSTRY MARKET, BY COUNTRY
4.5 FOOD INDUSTRY
4.5.1 FOOD INDUSTRY MARKET, BY COUNTRY
4.6 OTHERS
4.6.1 OTHERS MARKET, BY COUNTRY
5 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY COUNTRY
5.1 OVERVIEW
5.2 AUSTRALIA
5.2.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.2.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.2.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
5.3 CHINA
5.3.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.3.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.3.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
5.4 INDIA
5.4.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.4.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.4.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
5.5 JAPAN
5.5.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.5.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.5.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
5.6 SOUTH KOREA
5.6.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.6.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.6.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
5.7 INDONESIA
5.7.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.7.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.7.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
5.8 SINGAPORE
5.8.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.8.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.8.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
5.9 TAIWAN
5.9.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.9.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.9.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
5.10 THAILAND
5.10.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.10.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.10.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
5.11 REST OF ASIA-PACIFIC
5.11.1 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
5.11.2 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT
5.11.3 ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER
6 COMPANY PROFILES
6.1 INOTIV INC.
6.1.1 COMPANY OVERVIEW
6.1.2 COMPANY SNAPSHOT
6.1.3 OPERATING BUSINESS SEGMENTS
6.1.4 PRODUCT PORTFOLIO
6.1.5 BUSINESS PERFORMANCE
6.1.6 BUSINESS SEGMENTS
6.1.7 GEOGRAPHIC SEGMENTS
6.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.1.9 PRIMARY MARKET COMPETITORS
6.2 BIO-RAD LABORATORIES INC.
6.2.1 COMPANY OVERVIEW
6.2.2 COMPANY SNAPSHOT
6.2.3 OPERATING BUSINESS SEGMENTS
6.2.4 PRODUCT PORTFOLIO
6.2.5 BUSINESS PERFORMANCE
6.2.6 BUSINESS SEGMENTS
6.2.7 GEOGRAPHIC SEGMENTS
6.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.2.9 PRIMARY MARKET COMPETITORS
6.3 EVOTEC A.G.
6.3.1 COMPANY OVERVIEW
6.3.2 COMPANY SNAPSHOT
6.3.3 OPERATING BUSINESS SEGMENTS
6.3.4 PRODUCT PORTFOLIO
6.3.5 BUSINESS PERFORMANCE
6.3.6 BUSINESS SEGMENTS
6.3.7 GEOGRAPHIC SEGMENTS
6.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.3.9 PRIMARY MARKET COMPETITORS
6.4 AGILENT TECHNOLOGIES INC.
6.4.1 COMPANY OVERVIEW
6.4.2 COMPANY SNAPSHOT
6.4.3 OPERATING BUSINESS SEGMENTS
6.4.4 PRODUCT PORTFOLIO
6.4.5 BUSINESS PERFORMANCE
6.4.6 BUSINESS SEGMENTS
6.4.7 GEOGRAPHIC SEGMENTS
6.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.4.9 PRIMARY MARKET COMPETITORS
6.5 WUXI APPTEC
6.5.1 COMPANY OVERVIEW
6.5.2 COMPANY SNAPSHOT
6.5.3 OPERATING BUSINESS SEGMENTS
6.5.4 PRODUCT PORTFOLIO
6.5.5 BUSINESS PERFORMANCE
6.5.6 BUSINESS SEGMENTS
6.5.7 GEOGRAPHIC SEGMENTS
6.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.5.9 PRIMARY MARKET COMPETITORS
6.6 BRUKER
6.6.1 COMPANY OVERVIEW
6.6.2 COMPANY SNAPSHOT
6.6.3 OPERATING BUSINESS SEGMENTS
6.6.4 PRODUCT PORTFOLIO
6.6.5 BUSINESS PERFORMANCE
6.6.6 BUSINESS SEGMENTS
6.6.7 GEOGRAPHIC SEGMENTS
6.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.6.9 PRIMARY MARKET COMPETITORS
6.7 PERKINELMER INC.
6.7.1 COMPANY OVERVIEW
6.7.2 COMPANY SNAPSHOT
6.7.3 OPERATING BUSINESS SEGMENTS
6.7.4 PRODUCT PORTFOLIO
6.7.5 BUSINESS PERFORMANCE
6.7.6 BUSINESS SEGMENTS
6.7.7 GEOGRAPHIC SEGMENTS
6.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.7.9 PRIMARY MARKET COMPETITORS
6.8 ENZO BIOCHEM INC.
6.8.1 COMPANY OVERVIEW
6.8.2 COMPANY SNAPSHOT
6.8.3 OPERATING BUSINESS SEGMENTS
6.8.4 PRODUCT PORTFOLIO
6.8.5 BUSINESS PERFORMANCE
6.8.6 BUSINESS SEGMENTS
6.8.7 GEOGRAPHIC SEGMENTS
6.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.8.9 PRIMARY MARKET COMPETITORS
6.9 DANAHER CORPORATION
6.9.1 COMPANY OVERVIEW
6.9.2 COMPANY SNAPSHOT
6.9.3 OPERATING BUSINESS SEGMENTS
6.9.4 PRODUCT PORTFOLIO
6.9.5 BUSINESS PERFORMANCE
6.9.6 BUSINESS SEGMENTS
6.9.7 GEOGRAPHIC SEGMENTS
6.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.9.9 PRIMARY MARKET COMPETITORS
6.10 EUROFINS SCIENTIFIC SE
6.10.1 COMPANY OVERVIEW
6.10.2 COMPANY SNAPSHOT
6.10.3 OPERATING BUSINESS SEGMENTS
6.10.4 PRODUCT PORTFOLIO
6.10.5 BUSINESS PERFORMANCE
6.10.6 BUSINESS SEGMENTS
6.10.7 GEOGRAPHIC SEGMENTS
6.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.10.9 PRIMARY MARKET COMPETITORS
6.11 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
6.11.1 COMPANY OVERVIEW
6.11.2 COMPANY SNAPSHOT
6.11.3 OPERATING BUSINESS SEGMENTS
6.11.4 PRODUCT PORTFOLIO
6.11.5 BUSINESS PERFORMANCE
6.11.6 BUSINESS SEGMENTS
6.11.7 GEOGRAPHIC SEGMENTS
6.11.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.11.9 PRIMARY MARKET COMPETITORS
6.12 LABCORP DRUG DEVELOPMENT.
6.12.1 COMPANY OVERVIEW
6.12.2 COMPANY SNAPSHOT
6.12.3 OPERATING BUSINESS SEGMENTS
6.12.4 PRODUCT PORTFOLIO
6.12.5 BUSINESS PERFORMANCE
6.12.6 BUSINESS SEGMENTS
6.12.7 GEOGRAPHIC SEGMENTS
6.12.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.12.9 PRIMARY MARKET COMPETITORS
6.13 PROMEGA CORPORATION
6.13.1 COMPANY OVERVIEW
6.13.2 COMPANY SNAPSHOT
6.13.3 OPERATING BUSINESS SEGMENTS
6.13.4 PRODUCT PORTFOLIO
6.13.5 BUSINESS PERFORMANCE
6.13.6 BUSINESS SEGMENTS
6.13.7 GEOGRAPHIC SEGMENTS
6.13.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.13.9 PRIMARY MARKET COMPETITORS
6.14 INSPHERO AG
6.14.1 COMPANY OVERVIEW
6.14.2 COMPANY SNAPSHOT
6.14.3 OPERATING BUSINESS SEGMENTS
6.14.4 PRODUCT PORTFOLIO
6.14.5 BUSINESS PERFORMANCE
6.14.6 BUSINESS SEGMENTS
6.14.7 GEOGRAPHIC SEGMENTS
6.14.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.14.9 PRIMARY MARKET COMPETITORS
6.15 THERMO FISHER SCIENTIFIC INC.
6.15.1 COMPANY OVERVIEW
6.15.2 COMPANY SNAPSHOT
6.15.3 OPERATING BUSINESS SEGMENTS
6.15.4 PRODUCT PORTFOLIO
6.15.5 BUSINESS PERFORMANCE
6.15.6 BUSINESS SEGMENTS
6.15.7 GEOGRAPHIC SEGMENTS
6.15.8 KEY STRATEGIC MOVES AND DEVELOPMENT
6.15.9 PRIMARY MARKET COMPETITORS
LIST OF TABLES
TABLE 1. ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 2. ASIA-PACIFIC IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 3. ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 4. ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 5. ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY COUNTRY, 2022-2030, MILLION USD
TABLE 6. AUSTRALIA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 7. AUSTRALIA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 8. AUSTRALIA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 9. AUSTRALIA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 10. CHINA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 11. CHINA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 12. CHINA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 13. CHINA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 14. INDIA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 15. INDIA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 16. INDIA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 17. INDIA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 18. INDONESIA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 19. INDONESIA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 20. INDONESIA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 21. INDONESIA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 22. JAPAN EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 23. JAPAN IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 24. JAPAN EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 25. JAPAN EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 26. SINGAPORE EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 27. SINGAPORE IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 28. SINGAPORE EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 29. SINGAPORE EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 30. SOUTH KOREA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 31. SOUTH KOREA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 32. SOUTH KOREA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 33. SOUTH KOREA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 34. TAIWAN EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 35. TAIWAN IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 36. TAIWAN EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 37. TAIWAN EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 38. THAILAND EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 39. THAILAND IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 40. THAILAND EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 41. THAILAND EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 42. REST OF ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 43. REST OF ASIA-PACIFIC IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
TABLE 44. REST OF ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
TABLE 45. REST OF ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
TABLE 46. INOTIV INC.: COMPANY SNAPSHOT
TABLE 47. INOTIV INC: OPERATING SEGMENTS
TABLE 48. INOTIV INC.: PR0DUCT PORTFOLIO
TABLE 49. INOTIV INC.: BUSINESS SEGMENT
TABLE 50. INOTIV INC.: GEOGRAPHIC SEGMENT
TABLE 51. INOTIV INC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 52. BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
TABLE 53. BIO-RAD LABORATORIES INC: OPERATING SEGMENTS
TABLE 54. BIO-RAD LABORATORIES INC: PRODUCT PORTFOLIO
TABLE 55. BIO-RAD LABORATORIES INC: BUSINESS SEGMENT
TABLE 56. BIO-RAD LABORATORIES INC: GEOGRAPHIC SEGMENT
TABLE 57. BIO-RAD LABORATORIES INC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 58. EVOTEC A.G.: COMPANY SNAPSHOT
TABLE 59. EVOTEC A.G.: OPERATING SEGMENTS
TABLE 60. EVOTEC A.G.: PRODUCT PORTFOLIO
TABLE 61. EVOTEC A.G.: BUSINESS SEGMENT
TABLE 62. EVOTEC A.G.: GEOGRAPHIC SEGMENT
TABLE 63. EVOTEC A.G.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 64. AGILENT TECHNOLOGIES INC: COMPANY SNAPSHOT
TABLE 65. AGILENT TECHNOLOGIES INC: OPERATING SEGMENTS
TABLE 66. AGILENT TECHNOLOGIES INC: PRODUCT PORTFOLIO
TABLE 67. AGILENT TECHNOLOGIES INC: BUSINESS SEGMENT
TABLE 68. AGILENT TECHNOLOGIES INC: GEOGRAPHIC SEGMENT
TABLE 69. AGILENT TECHNOLOGIES INC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 70. WUXI APPTEC.: COMPANY SNAPSHOT
TABLE 71. WUXI APPTEC: OPERATING SEGMENTS
TABLE 72. WUXI APPTEC.: PR0DUCT PORTFOLIO
TABLE 73. WUXI APPTEC.: BUSINESS SEGMENT
TABLE 74. WUXI APPTEC.: GEOGRAPHIC SEGMENT
TABLE 75. WUXI APPTEC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 76. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 77. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 78. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 79. THERMO FISHER SCIENTIFIC: BUSINESS SEGMENT
TABLE 80. THERMO FISHER SCIENTIFIC: GEOGRAPHIC SEGMENT
TABLE 81. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 82. BRUKER: COMPANY SNAPSHOT
TABLE 83. BRUKER: OPERATING SEGMENTS
TABLE 84. BRUKER: PRODUCT PORTFOLIO
TABLE 85. BRUKER: BUSINESS SEGMENT
TABLE 86. BRUKER: GEOGRAPHIC SEGMENT
TABLE 87. BRUKER: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 88. PERKINELMER INC.: COMPANY SNAPSHOT
TABLE 89. PERKINELMER INC.: OPERATING SEGMENTS
TABLE 90. PERKINELMER INC.: PRODUCT PORTFOLIO
TABLE 91. PERKINELMER INC.: BUSINESS SEGMENT
TABLE 92. PERKINELMER INC.: GEOGRAPHIC SEGMENT
TABLE 93. PERKINELMER INC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 94. ENZO BIOCHEM INC.: COMPANY SNAPSHOT
TABLE 95. ENZO BIOCHEM INC.: OPERATING SEGMENTS
TABLE 96. ENZO BIOCHEM INC.: PRODUCT PORTFOLIO
TABLE 97. ENZO BIOCHEM INC.: BUSINESS SEGMENT
TABLE 98. ENZO BIOCHEM INC.: GEOGRAPHIC SEGMENT
TABLE 99. ENZO BIOCHEM INC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 100. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 101. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 102. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 103. DANAHER CORPORATION: BUSINESS SEGMENT
TABLE 104. DANAHER CORPORATION: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 105. EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
TABLE 106. EUROFINS SCIENTIFIC SE: PRODUCT PORTFOLIO
TABLE 107. EUROFINS SCIENTIFIC SE: GEOGRAPHIC SEGMENT
TABLE 108. EUROFINS SCIENTIFIC SE: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 109. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 110. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: OPERATING SEGMENTS
TABLE 111. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCT PORTFOLIO
TABLE 112. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS SEGMENT
TABLE 113. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: GEOGRAPHIC SEGMENT
TABLE 114. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 115. LABCORP DRUG DEVELOPMENT.: COMPANY SNAPSHOT
TABLE 116. LABCORP DRUG DEVELOPMENT.: OPERATING SEGMENTS
TABLE 117. LABCORP DRUG DEVELOPMENT.: PRODUCT PORTFOLIO
TABLE 118. LABCORP DRUG DEVELOPMENT.: BUSINESS SEGMENT
TABLE 119. LABCORP DRUG DEVELOPMENT.: GEOGRAPHIC SEGMENT
TABLE 120. LABCORP DRUG DEVELOPMENT.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 121. PROMEGA CORPORATION: COMPANY SNAPSHOT
TABLE 122. PROMEGA CORPORATION: PRODUCT PORTFOLIO
TABLE 123. INSPHERO AG: COMPANY SNAPSHOT
TABLE 124. INSPHERO AG: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 1. ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 2. ASIA-PACIFIC IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 3. ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 4. ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 5. ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY COUNTRY, 2022-2030, MILLION USD
FIGURE 6. AUSTRALIA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 7. AUSTRALIA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 8. AUSTRALIA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 9. AUSTRALIA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 10. CHINA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 11. CHINA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 12. CHINA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 13. CHINA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 14. INDIA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 15. INDIA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 16. INDIA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 17. INDIA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 18. INDONESIA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 19. INDONESIA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 20. INDONESIA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 21. INDONESIA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 22. JAPAN EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 23. JAPAN IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 24. JAPAN EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 25. JAPAN EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 26. SINGAPORE EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 27. SINGAPORE IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 28. SINGAPORE EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 29. SINGAPORE EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 30. SOUTH KOREA EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 31. SOUTH KOREA IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 32. SOUTH KOREA EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 33. SOUTH KOREA EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 34. TAIWAN EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 35. TAIWAN IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 36. TAIWAN EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 37. TAIWAN EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 38. THAILAND EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 39. THAILAND IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 40. THAILAND EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 41. THAILAND EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 42. REST OF ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 43. REST OF ASIA-PACIFIC IN VITRO MARKET, BY TECHNIQUE, 2022-2030, MILLION USD
FIGURE 44. REST OF ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY TOXICITY ENDPOINTS, 2022-2030, MILLION USD
FIGURE 45. REST OF ASIA-PACIFIC EARLY TOXICITY TESTING MARKET, BY END USER, 2022-2030, MILLION USD
FIGURE 46. INOTIV INC.: NET SALES, 2020–2022 ($MILLION)
FIGURE 47. INOTIV INC: PRIMARY MARKET COMPETITORS
FIGURE 48. BIO-RAD LABORATORIES INC CO: NET SALES, 2020–2022 ($MILLION)
FIGURE 49. BIO-RAD LABORATORIES INC: PRIMARY MARKET COMPETITORS
FIGURE 50. EVOTEC A.G.: NET SALES, 2019–2021 ($MILLION)
FIGURE 51. EVOTEC A.G.: PRIMARY MARKET COMPETITORS
FIGURE 52. AGILENT TECHNOLOGIES INC: NET SALES, 2020–2022 ($MILLION)
FIGURE 53. AGILENT TECHNOLOGIES INC: PRIMARY MARKET COMPETITORS
FIGURE 54. WUXI APPTEC.: NET SALES, 2020–2022 ($MILLION)
FIGURE 55. WUXI APPTEC: PRIMARY MARKET COMPETITORS
FIGURE 56. THERMO FISHER SCIENTIFIC: NET SALES, 2019–2021 ($MILLION)
FIGURE 57. THERMO FISHER SCIENTIFIC: PRIMARY MARKET COMPETITORS
FIGURE 58. BRUKER: NET SALES, 2019–2021 ($MILLION)
FIGURE 59. BRUKER: PRIMARY MARKET COMPETITORS
FIGURE 60. PERKINELMER INC.: NET SALES, 2020–2022 ($MILLION)
FIGURE 61. PERKINELMER INC.: PRIMARY MARKET COMPETITORS
FIGURE 62. ENZO BIOCHEM INC.: NET SALES, 2019–2021 ($MILLION)
FIGURE 63. ENZO BIOCHEM INC.: PRIMARY MARKET COMPETITORS
FIGURE 64. DANAHER CORPORATION: NET SALES, 2020–2022 ($MILLION)
FIGURE 65. DANAHER CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 66. EUROFINS SCIENTIFIC SE CO: NET SALES, 2020–2022 ($MILLION)
FIGURE 67. EUROFINS SCIENTIFIC SE: PRIMARY MARKET COMPETITORS
FIGURE 68. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CO: NET SALES, 2020–2022 ($MILLION)
FIGURE 69. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRIMARY MARKET COMPETITORS
FIGURE 70. LABCORP DRUG DEVELOPMENT. CO: NET SALES, 2020–2022 ($MILLION)
FIGURE 71. LABCORP DRUG DEVELOPMENT.: PRIMARY MARKET COMPETITORS
FIGURE 72. PROMEGA CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 73. INSPHERO AG: PRIMARY MARKET COMPETITORS